INTERNATIONAL PATENT: UROGEN PHARMA LTD. FILES APPLICATION FOR "TREATMENT OF LOW-GRADE INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER WITH A THERMALLY GELLING PHARMACEUTICAL COMPOSITION CONTAINING MITOMYCIN"

GENEVA, Feb. 3 -- UROGEN PHARMA LTD. (9 Ha'Ta'asiya Street4365007 Ra'anana) filed a patent application (PCT/IB2024/057229) for "TREATMENT OF LOW-GRADE INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER WITH A THERMALLY GELLING PHARMACEUTICAL COMPOSITION CONTAINING MITOMYCIN" on Jul 25, 2024. With publication no. WO/2025/022354, the details related to the patent application was published on Jan 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RAJU, Sunil (400 Alexander ParkPrinceton, New Jersey 08540)

Abstract: A method of reducing risk of bladder tumor recurrence, progression or deat...